Pulsed high-dose dexamethasone treatment of polyneuropathy associated with monoclonal gammopathy

[1]  M. Vermeulen,et al.  Pulsed high dose dexamethasone treatment in chronic inflammatory demyelinating polyneuropathy: a pilot study. , 1997, Journal of neurology, neurosurgery, and psychiatry.

[2]  H. Franssen,et al.  Intermittent cyclophosphamide and prednisone treatment of polyneuropathy associated with monoclonal gammopathy of undetermined significance , 1996, Neurology.

[3]  É. Oksenhendler,et al.  Plasma exchange and chlorambucil in polyneuropathy associated with monoclonal IgM gammopathy. IgM-associated Polyneuropathy Study Group. , 1995, Journal of neurology, neurosurgery, and psychiatry.

[4]  N. Latov.  Pathogenesis and therapy of neuropathies associated with monoclonal gammopathies , 1995, Annals of neurology.

[5]  H. Franssen,et al.  Polyneuropathy associated with monoclonal gammopathy of undetermined significance. A prospective study of the prognostic value of clinical and laboratory abnormalities. , 1994, Brain : a journal of neurology.

[6]  J. Andersen.  Response of resistant idiopathic thrombocytopenic purpura to pulsed high-dose dexamethasone therapy. , 1994, The New England journal of medicine.

[7]  B. Barlogie,et al.  Primary dexamethasone treatment of multiple myeloma. , 1992, Blood.

[8]  A. Windebank,et al.  Plasma exchange in polyneuropathy associated with monoclonal gammopathy of undetermined significance. , 1991, The New England journal of medicine.

[9]  S. Barbieri,et al.  Treatment of patients with neuropathy and anti‐MAG IgM M‐proteins , 1988, Annals of neurology.